Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(24 sites)
United States
Hoag Memorial Presbyterian, Newport Beach, California Florida Cancer Specialists and Research Institute, Lake Mary, Florida Washington University School of Medicine, St Louis, Missouri Titan Health Partners Llc Dba Astera Cancer Care, East Brunswick, New Jersey Avera Cancer Institute, Sioux Falls, South Dakota